Ligand validation:7CJJ

HTG: heptyl 1-thio-beta-D-glucopyranoside

HTG is a Ligand Of Interest in 7CJJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7CJJ_HTG_B_624	78%	36%	0.111	0.954	1.12	1.41	2	3	0	0	100%	1
7CJJ_HTG_b_624	67%	38%	0.129	0.938	1.03	1.4	2	4	0	0	100%	1
7CJJ_HTG_b_621	22%	39%	0.197	0.814	1.01	1.35	2	4	0	0	100%	1
7CJJ_HTG_B_621	20%	34%	0.232	0.838	0.98	1.6	1	4	0	0	100%	1
7CJJ_HTG_C_523	13%	39%	0.325	0.87	0.92	1.46	1	2	0	0	100%	1
7CJJ_HTG_c_523	11%	40%	0.301	0.823	0.99	1.33	2	1	0	0	100%	1
7CJJ_HTG_h_101	8%	22%	0.298	0.8	1.16	2.03	2	7	0	0	84%	0.8421
7CJJ_HTG_B_622	6%	42%	0.354	0.793	0.85	1.39	1	1	0	0	100%	1
7CJJ_HTG_V_202	4%	63%	0.389	0.836	0.19	1.21	-	1	0	0	58%	0.5789
7CJJ_HTG_D_411	2%	37%	0.329	0.602	1.05	1.41	2	1	0	0	84%	0.8421
7CJJ_HTG_b_622	0%	33%	0.572	0.626	1.02	1.62	1	2	0	0	100%	1
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	37%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	37%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	35%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	45%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.